FRI442 Ongoing Clomiphene Treatment For Men With Hypogonadotropic Hypogonadism

Disclosure: S.R. Smith: None. Context: Male hypogonadism is becoming recognized with increasing frequency. Testosterone products remain the only approved medical therapy, although highly problematic in men with hypogonadotropic hypogonadism because of inconvenient routes of administration, high cost...

Descripción completa

Detalles Bibliográficos
Autor principal: Smith, Stephen Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554922/
http://dx.doi.org/10.1210/jendso/bvad114.1631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554922/
http://dx.doi.org/10.1210/jendso/bvad114.1631

Ejemplares similares